CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+2.58%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.09B
AUM Growth
+$1.09B
(-1.2%)
Cap. Flow
+$61.1M
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
67.6%
Holding
30
New
7
Increased
10
Reduced
9
Closed
4
Top Buys
| 1 |
United Therapeutics
UTHR
|
$63.7M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
$51.8M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$50.3M |
| 4 |
Dynavax Technologies
DVAX
|
$32.9M |
| 5 |
Pacira BioSciences
PCRX
|
$32.2M |
Top Sells
| 1 |
MiMedx Group
MDXG
|
$75.5M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$66.9M |
| 3 |
argenx
ARGX
|
$49.5M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$45.4M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$20.3M |
Sector Composition
| 1 | Healthcare | 89.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
| $104M | 9.53% | 2,900,893 +251,608 | +9% | +$9.04M |
|
|
SPPI
2
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $99.8M | 9.12% | 6,203,356 -1,180,110 | -16% | -$19M |
|
3
Corcept Therapeutics
CORT
$7.35B
| $85.3M | 7.8% | 5,188,417 -591,089 | -10% | -$9.72M |
|
4
Travere Therapeutics
TVTX
$1.56B
| $82.6M | 7.55% | 3,693,371 +48,933 | +1% | +$1.09M |
|
|
5
Pacira BioSciences
PCRX
$1.2B
| $82.1M | 7.5% | 2,634,916 +1,032,582 | +64% | +$32.2M |
|
|
6
United Therapeutics
UTHR
$13.8B
| $63.7M | 5.82% | +566,926 | New | +$63.7M |
|
|
NUVA
7
DELISTED
NuVasive, Inc.
NUVA
| $57.4M | 5.25% | 1,099,523 +424,523 | +63% | +$22.2M |
|
8
UroGen Pharma
URGN
$900M
| $57M | 5.2% | 1,146,197 +229,747 | +25% | +$11.4M |
|
|
9
Iovance Biotherapeutics
IOVA
$807M
| $54.2M | 4.95% | 3,206,073 +2,973,677 | +1,280% | +$50.3M |
|
|
AMRN
10
Amarin Corp
AMRN
$311M
| $53.4M | 4.88% | 17,729,933 -6,746,587 | -28% | -$20.3M |
|
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $51.8M | 4.73% | +3,072,275 | New | +$51.8M |
|
|
STML
12
DELISTED
Stemline Therapeutics, Inc.
STML
| $39.9M | 3.64% | 2,606,598 +256,806 | +11% | +$3.93M |
|
|
13
Dynavax Technologies
DVAX
$1.19B
| $32.9M | 3.01% | +1,658,795 | New | +$32.9M |
|
14
Vericel Corp
VCEL
$1.83B
| $30.9M | 2.82% | 3,104,592 -276,711 | -8% | -$2.75M |
|
|
GWPH
15
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $30.7M | 2.81% | 272,700 -402,792 | -60% | -$45.4M |
|
|
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $29.1M | 2.66% | 2,339,184 +1,219,297 | +109% | +$15.2M |
|
17
Pacific Biosciences
PACB
$393M
| $25.8M | 2.36% | 12,576,002 +5,510,082 | +78% | +$11.3M |
|
18
Savara
SVRA
$567M
| $24.9M | 2.28% | 2,711,190 -44,822 | -2% | -$412K |
|
19
uniQure
QURE
$896M
| $24.6M | 2.24% | +1,045,065 | New | +$24.6M |
|
20
ADMA Biologics
ADMA
$4.12B
| $15.3M | 1.4% | 3,329,234 -38,401 | -1% | -$177K |
|
21
Catalyst Pharmaceutical
CPRX
$2.52B
| $11.9M | 1.09% | 4,994,719 +521,112 | +12% | +$1.25M |
|
|
CSII
22
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.78M | 0.89% | +446,100 | New | +$9.78M |
|
23
ANI Pharmaceuticals
ANIP
$2.03B
| $8.32M | 0.76% | 142,943 -35 | -0% | -$2.04K |
|
|
RARX
24
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7.73M | 0.71% | +1,454,761 | New | +$7.73M |
|
|
CVRS
25
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $6.27M | 0.57% | 4,574,835 -1,411,170 | -24% | -$1.93M |
|